New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Available in Thailand
PR Newswire —
Eligible women with breast cancer in Thailand now have access to a new therapy, NERLYNX® (neratinib), for the first time The launch of NERLYNX provides an important new treatment option for women diagnosed with human epidermal growth factor receptor 2 positive (HER2+) breast cancer This...